Same road, different paths

Although competitors Idec Pharmaceuticals Corp. and Coulter Pharmaceutical Inc. are developing antibodies to treat cancer, their partnering strategies for drug discovery differ. IDPH is taking an upstream approach to collaborations, looking for a genomics partner able to provide gene discovery and validation. CLTR is looking slightly further downstream for both antigen targets and antibody generation technologies, as